First Trust Nasdaq Pharmaceuticals ETF (FTXH)

NASD · US Equities - Industry Sector · USA

Are the companies inside FTXH undervalued?

The companies inside FTXH trade 22% above what we estimate they are worth. We could give a verdict on 94% of the fund's weight: 51 holdings as reported to the SEC at 30 Jun 2026.

Where the money is: 18% in companies in the buy zone, 4% about fairly valued, 72% overvalued, 6% without a verdict.

What does FTXH hold?

The ten largest holdings, with our verdict on each:

How much does the FTXH fee cost?

Its expense ratio is 0.60% a year: on $10,000 held flat that is $600 over 10 years and $1,200 over 20.

Browse

Other US Equities - Industry Sector ETFs